Xponential Fitness Q4 revenue USD 83.0 million down 26% Adjusted EBITDA to USD 22.9 million

Reuters
02/27
<a href="https://laohu8.com/S/XPOF">Xponential Fitness</a> Q4 revenue USD 83.0 million down 26% Adjusted EBITDA to USD 22.9 million

Xponential (XPOF) reported Q4 FY 2025 revenue of USD 83.0 million and a net loss of USD 45.6 million, with Adjusted EBITDA of USD 22.9 million. North America system-wide sales in Q4 were USD 446.7 million (+5.0%), while North America same store sales fell 4% and quarterly run-rate average unit volume (AUV) was USD 683,000. For FY 2025, Xponential posted revenue of USD 314.9 million (-2.0%), a net loss of USD 53.7 million, and Adjusted EBITDA of USD 111.8 million. North America system-wide sales were USD 1.75 billion (+13.0%) and North America same store sales rose 0.5%. The company said it sold 179 franchise licenses and opened 341 gross new studios in 2025. Xponential highlighted regulatory and legal updates, including an agreement to pay USD 17.0 million over 12 months to resolve the previously disclosed FTC investigation, subject to approvals, and a finalized USD 22.75 million settlement with over 500 current and former franchisees to be paid over 35 months. For 2026, it guided to revenue of USD 260.0 million to USD 270.0 million and Adjusted EBITDA of USD 100.0 million to USD 110.0 million, with net new studio openings expected at 150 to 170 and North America system-wide sales of USD 1.72 billion to USD 1.80 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xponential Fitness Inc. published the original content used to generate this news brief on February 26, 2026, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10